Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Works of Sumithira Vasu being referenced
A novel method to expand large numbers of CD56+ natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation
2015
FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sumithira Vasu | 347 | 308 | 246 | 48 | 680 | |
| Johanna Svahn | 437 | 213 | 285 | 31 | 804 | |
| Shin‐ichiro Mori | 459 | 187 | 105 | 38 | 699 | |
| Takero Shindo | 227 | 207 | 176 | 58 | 589 | |
| Guibin Chen | 491 | 517 | 168 | 31 | 849 | |
| J. L. Harousseau | 428 | 131 | 194 | 33 | 797 | |
| Kazuhiro Mochizuki | 192 | 282 | 179 | 47 | 622 | |
| Panayotis Kaloyannidis | 161 | 166 | 128 | 40 | 604 | |
| Sumithira Vasu | 402 | 223 | 142 | 77 | 805 | |
| Jeffrey J. Pu | 141 | 262 | 209 | 49 | 660 | |
| Takamasa Katagiri | 344 | 261 | 86 | 63 | 623 |
All Works
Loading papers...